Correlation Between Effector Therapeutics and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Cidara Therapeutics, you can compare the effects of market volatilities on Effector Therapeutics and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Cidara Therapeutics.
Diversification Opportunities for Effector Therapeutics and Cidara Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Effector and Cidara is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Cidara Therapeutics
If you would invest 1,283 in Cidara Therapeutics on August 31, 2024 and sell it today you would earn a total of 737.00 from holding Cidara Therapeutics or generate 57.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Effector Therapeutics vs. Cidara Therapeutics
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cidara Therapeutics |
Effector Therapeutics and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Cidara Therapeutics
The main advantage of trading using opposite Effector Therapeutics and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Cidara Therapeutics vs. Cue Biopharma | Cidara Therapeutics vs. Eliem Therapeutics | Cidara Therapeutics vs. Inhibrx | Cidara Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |